Clinical Trials Browser

OTHER × Interventional × MEK inhibitor I × Clear all

NCT06322095 2024-10-01

A Study of GH21 Combined With Previous Target Therapy or Immunotherapy in Patients With Advanced Solid Tumors

Phase 2 Recruiting

Other solid neoplasm

Patients With Advanced Solid Tumor

NCT02382549 2023-12-12

Mel61

Phase EARLY_PHASE1 Terminated

Melanoma

NCT01029418 2015-04-16

AZD6244 and Sorafenib in Advanced Hepatocellular Carcinoma

Phase 1/2 Terminated

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms